NH · Concall Summary
NARAYANA HRUDAYALAYA LTD.
The earnings call for Narayana Hrudayalaya Limited on August 3, 2026, discussed the company's performance for the quarter ended June 30, 2026. Management highlighted a 40% EBITDA growth despite no new bed additions in recent years, attributing this to increased high-end procedures and technology use. They noted a rise in patient footfalls, contributing to revenue growth alongside average revenue per occupied bed (ARPOB). However, management acknowledged challenges in the insurance segment, citing a spike in losses due to a few large claims and the small size of the insurance book. They emphasized ongoing initiatives to improve claims management and portfolio sustainability. The management also addressed the UK business, indicating early integration challenges but expressing optimism about future growth and margin improvement. Overall, the call reflected a focus on operational efficiency and strategic growth across domestic and international markets.
The management conveyed both positive growth metrics and challenges in the insurance segment.
View source filing →Earlier concalls
- 2026-08-03 — The investor presentation from Narayana Hrudayalaya Ltd. for the quarter ended June 30, 2026, reported a consolidated op…
- 2026-07-31 — The investor presentation for Narayana Hrudayalaya Ltd. for the quarter ended June 30, 2026, reported consolidated opera…
- 2026-05-22 — The investor presentation for Narayana Hrudayalaya Ltd. for the quarter and financial year ended March 31, 2026, reporte…
See NH's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.
Sign up free